Physician
Child & Adolescent Clinic, PS
Child & Adolescent Clinic, PS was paid $21.83M by Medicaid between Jan 2018 and Dec 2024, across 94 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.
33Billing provider infoCHILD & ADOLESCENT CLINIC, PS
LONGVIEW, WA 98632
LONGVIEW, WA 98632
33aNPI1144275777assigned 05/23/2006
33bProvider typePediatrics Physician
28Total paid$21.83M
24GClaims649,407
24DCodes billed94
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Washington
Rank by total paid#3 of 110
Median peer was paid$57K
This provider vs. median385×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 89,586 | $3.15M | |
| 2019 | 88,951 | $3.30M | |
| 2020 | 79,080 | $2.53M | |
| 2021 | 102,923 | $3.03M | |
| 2022 | 116,104 | $3.44M | |
| 2023 | 104,224 | $3.34M | |
| 2024incomplete | 68,539 | $3.06M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 63,988 | 60,837 | $6.37M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 62,205 | 59,888 | $4.40M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.6% | 20,163 | 19,897 | $1.88M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.3% | 17,324 | 17,159 | $1.59M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.1% | 12,742 | 12,465 | $1.11M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.0% | 8,784 | 8,700 | $869K |
| 92552 | 3.2% | 33,690 | 33,222 | $689K | |
| 99499 | 2.6% | 21,606 | 21,248 | $562K | |
| 99429 | 2.2% | 17,944 | 17,618 | $473K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.1% | 3,117 | 2,945 | $448K |
| G9149 | National committee for quality assurance - level 2 medical home | 1.4% | 1,453 | 1,436 | $295K |
| 99051 | 1.3% | 10,036 | 9,816 | $288K |
82 more codes
| D0120 | Dental checkup, returning patient | 1.2% | 11,467 | $253K |
| D9999 | Unspecified adjunctive procedure, by report | <1% | 11,123 | $218K |
| 96127 | <1% | 62,528 | $194K | |
| 90686 | <1% | 11,311 | $188K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 4,170 | $174K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 4,232 | $152K |
| 90688 | <1% | 9,338 | $125K | |
| 90670 | <1% | 7,737 | $109K | |
| D1206 | Topical application of fluoride varnish | <1% | 6,932 | $90K |
| 99174 | <1% | 6,120 | $87K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,805 | $84K |
| 99188 | <1% | 7,479 | $83K | |
| 90648 | <1% | 6,535 | $83K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,293 | $74K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 9,834 | $71K |
| G9150 | National committee for quality assurance - level 3 medical home | <1% | 756 | $61K |
| 90680 | <1% | 3,477 | $53K | |
| 90723 | <1% | 3,524 | $45K | |
| 36416 | <1% | 12,525 | $43K | |
| 99173 | <1% | 26,548 | $40K | |
| 96160 | <1% | 19,237 | $40K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,537 | $38K |
| 99177 | <1% | 15,639 | $34K | |
| 83655 | <1% | 2,606 | $33K | |
| 90697 | <1% | 1,723 | $33K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,117 | $32K |
| 90633 | <1% | 2,337 | $32K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,088 | $32K |
| 90651 | <1% | 2,183 | $30K | |
| 85018 | <1% | 11,682 | $28K | |
| 90671 | <1% | 1,260 | $26K | |
| 80061 | Lipid panel | <1% | 1,818 | $24K |
| 0071A | <1% | 610 | $23K | |
| 99381 | <1% | 247 | $23K | |
| 0072A | <1% | 495 | $19K | |
| 99383 | <1% | 183 | $19K | |
| 90685 | <1% | 1,354 | $17K | |
| 90480 | <1% | 517 | $16K | |
| 96161 | <1% | 7,525 | $13K | |
| 0001A | <1% | 294 | $11K | |
| 90677 | <1% | 855 | $10K | |
| 0002A | <1% | 237 | $9K | |
| 90734 | <1% | 744 | $9K | |
| 99339 | <1% | 145 | $8K | |
| 90619 | <1% | 517 | $8K | |
| 99462 | <1% | 171 | $5K | |
| 90707 | <1% | 366 | $5K | |
| 99401 | <1% | 157 | $5K | |
| 90715 | <1% | 312 | $5K | |
| 90710 | <1% | 295 | $4K | |
| 99460 | <1% | 62 | $4K | |
| 99382 | <1% | 39 | $4K | |
| 90716 | <1% | 260 | $4K | |
| 0124A | <1% | 92 | $4K | |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | <1% | 107 | $3K |
| 0154A | <1% | 81 | $3K | |
| 90700 | <1% | 202 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 559 | $2K |
| 81003 | <1% | 961 | $2K | |
| 90696 | <1% | 115 | $2K | |
| 90661 | <1% | 889 | $2K | |
| 0003A | <1% | 48 | $2K | |
| 99001 | <1% | 115 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 28 | $2K |
| 0073A | <1% | 37 | $1K | |
| 90656 | <1% | 435 | $1K | |
| 94060 | <1% | 26 | $969.84 | |
| 0081A | <1% | 24 | $960.00 | |
| 90474 | <1% | 71 | $908.34 | |
| 94664 | <1% | 73 | $775.32 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 50 | $563.35 |
| 0054A | <1% | 14 | $560.00 | |
| 87807 | <1% | 37 | $496.99 | |
| 84703 | <1% | 66 | $468.60 | |
| 99072 | <1% | 69,990 | $133.42 | |
| 91319 | <1% | 27 | $39.51 | |
| 91320 | <1% | 25 | $31.44 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 42 | $25.87 |
| 99000 | <1% | 9,826 | $10.92 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 28 | $0.45 |
| A4322 | Irrigation syringe, bulb or piston, each | 0% | 16 | $0.00 |
| 94150 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCAVENS, PHYLLIS (PHYSICIAN/OWNER)